A new immunometabolic perspective of intervertebral disc degeneration
V Francisco, J Pino, MÁ González-Gay… - Nature Reviews …, 2022 - nature.com
Intervertebral disc (IVD) degeneration is a common finding on spine imaging that increases
in prevalence with age. IVD degeneration is a frequent cause of low back pain, which is a …
in prevalence with age. IVD degeneration is a frequent cause of low back pain, which is a …
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus
Evidence from observational studies and randomized trials suggests that prediabetes and
type 2 diabetes mellitus (T2DM) can develop in genetically susceptible individuals in …
type 2 diabetes mellitus (T2DM) can develop in genetically susceptible individuals in …
Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe
I Kyrou, C Tsigos, C Mavrogianni, G Cardon… - BMC endocrine …, 2020 - Springer
Background Type 2 diabetes mellitus (T2DM) comprises the vast majority of all diabetes
cases in adults, with alarmingly increasing prevalence over the past few decades worldwide …
cases in adults, with alarmingly increasing prevalence over the past few decades worldwide …
Protective effects of curcumin in cardiovascular diseases—Impact on oxidative stress and mitochondria
FF Cox, A Misiou, A Vierkant, N Ale-Agha, M Grandoch… - Cells, 2022 - mdpi.com
Cardiovascular diseases (CVDs) contribute to a large part of worldwide mortality. Similarly,
two of the major risk factors for these diseases, aging and obesity, are also global problems …
two of the major risk factors for these diseases, aging and obesity, are also global problems …
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
MK Mahapatra, M Karuppasamy, BM Sahoo - Reviews in Endocrine and …, 2022 - Springer
Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as
monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 …
monotherapy in both subcutaneous as well as oral dosage form (first approved oral GLP-1 …
Global and societal implications of the diabetes epidemic
P Zimmet, K Alberti, J Shaw - Nature, 2001 - nature.com
Abstract Changes in human behaviour and lifestyle over the last century have resulted in a
dramatic increase in the incidence of diabetes worldwide. The epidemic is chiefly of type 2 …
dramatic increase in the incidence of diabetes worldwide. The epidemic is chiefly of type 2 …
Abdominal obesity and metabolic syndrome
JP Després, I Lemieux - Nature, 2006 - nature.com
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders,
inflammation, insulin resistance or full-blown diabetes, and increased risk of developing …
inflammation, insulin resistance or full-blown diabetes, and increased risk of developing …
[HTML][HTML] The relationship between BMI and onset of diabetes mellitus and its complications
The Relationship between BMI and Onset of Diabetes Mellitus and its Complications - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Fructose, insulin resistance, and metabolic dyslipidemia
H Basciano, L Federico, K Adeli - Nutrition & metabolism, 2005 - Springer
Obesity and type 2 diabetes are occurring at epidemic rates in the United States and many
parts of the world. The" obesity epidemic" appears to have emerged largely from changes in …
parts of the world. The" obesity epidemic" appears to have emerged largely from changes in …
Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins
IS Wood, P Trayhurn - British journal of nutrition, 2003 - cambridge.org
The number of known glucose transporters has expanded considerably over the past 2
years. At least three, and up to six, Na+-dependent glucose transporters (SGLT1–SGLT6; …
years. At least three, and up to six, Na+-dependent glucose transporters (SGLT1–SGLT6; …